935
Views
61
CrossRef citations to date
0
Altmetric
ArticlesCritical Care

Tramadol overdose as a cause of serotonin syndrome: a case series

&
Pages 337-341 | Received 13 Nov 2009, Accepted 17 Feb 2010, Published online: 05 Apr 2010
 

Abstract

Introduction. Tramadol overdose impairs consciousness and may induce ECG changes and convulsions. These effects may be opioid and/or serotonin related. This study describes clinical manifestations, electrophysiological and hemodynamic findings, and the frequency of potential serotonin syndrome in tramadol overdose in a case series. It also focuses on potential factors by which convulsions could be predicted. Methods. This is a prospective observational case series. All cases admitted with suspected tramadol overdose from September 1, 2006 to August 31, 2007 were included. Results. Tramadol overdose accounted for 1.2% of all poisonings (n = 158), of which 65% were tramadol only. It was predominantly male (63%). Mean (SD) age was 22.6 (7.4) years. Among these cases, 24 (15%) experienced seizure and in 10 (6%) cases creatine phosphokinase increased. Death occurred in one patient. Seizure occurred more frequently in patients with tramadol use only [odds ratio 3.0, 95% confidence interval 1.1, 8.4] and mydriasis (odds ratio 8.9, 95% confidence interval 1.9, 42.4) on admission. Eight cases were treated for potential serotonin syndrome. Concurrent intoxication with central nervous system depressants, age, alleged dose, consciousness level, respiratory rate, history of drug abuse, and naloxone administration was not associated with the occurrence of seizures. Conclusion. In tramadol overdose, mydriasis or tachycardia appears to indicate a higher risk for seizure. Management may need to be focused on both μ-opioid agonism and potential mild serotonin syndrome.

Acknowledgment

We would like to acknowledge the kind cooperation of Dr. A. Shakiba for ECG interpretation in a preliminary related data set.

Declaration of interest

The authors report no conflicts of interest. The authors alone are responsible for the content and writing of this paper.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.